Slide 1: Global virtual wellness provider – Quarter one 2022
Global virtual wellness provider Quarter one 2022 (1 January 2021 – 31 March 2022) Webcast presentation | May 25th 10:00 CET
Slide 2: Forward-looking statement
Forward-looking statement This presentation contains certain forward-looking statements and opinions. Forward-looking statements are statements that do not relate to historical facts and events and such statements and opinions pertaining to the future that, for example, contain wording such as “beli
Slide 3: Agenda
Agenda Q1 in short Business update Financial results Strategy and outlook Q&A Henrik Molin CEO & co-founder Charlotte Goodwin CFO 3
Slide 4: Q1 in short
sb Physitrack:
Slide 5: Continuing to be in line with mid term targets
Continuing to be in line with mid Strategic acquisitions term targets Q1 2022 PT Courses 67% revenue growth - Strengthens our presence in USA and enhances our SaaS offering Wellnow Q1 2022 proforma 29% - Creates a footprint in Germany for revenue growth Virtual-first Wellness segment EBITDA increase
Slide 6: Business updates
Business updates sb Physitrack:
Slide 7: Continuing growth of underlying SaaS business
Continuing growth of underlying SaaS business 45,000 10% growth in Physitrack users and 3% growth in Physiotools licenses 40,000 10% 35,000 30,000 Retention focus • Creation of Customer Value Taskforce, focusing on product-led customer retention and 25,000 higher free trial conversion • Data driven
Slide 8: PT Courses
PT Courses On 26 January 2022 Physitrack PLC announced the acquisition of PT Courses, a company registered in the US, for cash consideration of $1.8 million with no earn-out. PT Courses, is a provider of continued education courses for physiotherapists and occupational therapy professionals in the U
Slide 9: Wellnow
Wellnow On 23 February 2022 Physitrack PLC announced the acquisition of Wellnow Group, a German virtual-first corporate wellness platform. Consideration is made up of EUR 2.5 million upfront and a further potential aggregate earn-out consideration of up to EUR 9 million over four years, subject to s
Slide 10: Champion Health
Champion Health On 6 May 2022 Physitrack PLC announced the acquisition of Champion Health, a leading workplace health platform based in the UK. Consideration is made up of GBP 2.5 million upfront and a further potential aggregate earn-out consideration of up to GBP 7.9 million over four years, subje
Slide 11: Financial Results
Financial Results sb Physitrack:
Slide 12: Q1 Financial Highlights
Q1 Financial Highlights 3 month revenue Churn 67% -% €2.6m (Q1 2021: €1.5m) 1.4% (Q1 2021: 1.9%) 5pp Operating cashflow 3 month proforma 29% -% revenue growth €0.5m (Q1 2021: €0.5m) 3 month adjusted EBITDA 3 month adjusted EBITDA margin 44% €0.7m (Q1 2021: €0.5m) 29% (2021: 34%) 5pp 12
Slide 13: Maintaining revenue growth
Maintaining revenue growth In-line with medium term growth targets Group Revenue SaaS revenue growth Virtual Wellness revenue growth 3.0 3.0 3.0 29% 2.5 2.5 2.5 23% 2.0 Euro Million 67% 2.0 2.0 Euro Million Euro Million 1.5 1.5 1.5 1.0 1.0 1.0 58% 0.5 0.5 0.5 - - - Q1 2021 Q2 2021 Q3 2021 Q4 2021 Q1
Slide 14: EBITDA – Stable growth excluding non-recurring costs
EBITDA Stable growth excluding non-recurring costs 0.8 3.0 0.7 44% 2.5 0.6 0.8 2.0 0.5 €0.4M €’million €’million 1.5 0.7 0.4 €0.7M €0.5M 0.3 1.0 ADJUSTED EBITDA Margin 0.6 ADJUSTED 0.2 29% EBITDA Margin 34% 0.5 €0.3M 0.7 0.1 0.5 - - 2021 ADJ EBITDA 2022 ADJ EBITDA 3 MONTHS 2021 3 MONTHS 2022 Non rec
Slide 15: Cashflow
CASHFLOW Cash reinvested in investing activities 16.0 14.0 (0.2) (0.0) 0.7 (0.9) 12.0 ( 4.2 ) 10.0 €’million (0.3) 0.1 8.0 13.3 6.0 8.5 4.0 2.0 - 1 Jan 2022 Opening Adjusted EBITDA Working capital Interest expense Purchase of intangibles Acqui stions net of cash M&A costs Fx 31 March 2022 Closing Ne
Slide 16: Balance Sheet
Balance Sheet Net assets position strengthened from goodwill and intangibles recognised on acquisitions 31 March 2022 31 December 2021 Euros ‘000 Goodwill, intangibles and PPE 28,111 17,221 Cash and cash equivalents 8,549 13,325 Borrowings - (1) Trade and other receivables 2,280 1,666 Inventory 69 6
Slide 17: Strategy and outlook
Strategy and outlook sb Physitrack:
Slide 18: Executing a well-defined growth plan combining organic and inorganic initiatives
Executing a well-defined growth plan combining organic and inorganic initiatives Planning to build a global powerhouse in the remote physical care space through well-defined, tangible organic and inorganic growth objectives 3 M&A initiative 2 Continue strong M&A integration to Organic growth levers
Slide 19: Physitrack's Wellness Ecosystem
Physitrack’s Wellness Ecosystem The market's most comprehensive holistic offering PREVENTION & WELLNESS (PHYSICAL) PREVENTION & WELLNESS (EMOTIONAL) POST-ACUTE POST-OP, CHR CARE PROVIS ANALYSIS & ASSESSMENT FOLLOW-UP & ANALYSIS >NIC N Testing and assessment Technology-led exercise Technology-led emo
Slide 20: Financial goals – What we aim for
Financial goals – What we aim for Top-line growth Profit margins Value creation/distribution Physitrack aims to achieve annual Physitrack targets an EBITDA margin of Physitrack aims to reinvest profits and organic sales growth exceeding 30% in 40-45% in the medium term, with cash flows in organic gr
Slide 21: sb Physitrack:
sb Physitrack: